-
1
-
-
44949169540
-
-
LAMICTAL (lamotrigine tablets) prescribing information September Accessed 25 Oct 2011
-
LAMICTAL (lamotrigine tablets) prescribing information. GlaxoSmithKline: September 2011. http://www.gsk.com/products/prescription-medicines/lamictal.htm. Accessed 25 Oct 2011.
-
(2011)
GlaxoSmithKline
-
-
-
2
-
-
44949169540
-
-
LAMICTAL XR (lamotrigine) extended-release tablets prescribing information September Accessed 25 Oct 2011
-
LAMICTAL XR (lamotrigine) extended-release tablets prescribing information. GlaxoSmithKline: September 2011. http://www.gsk.com/products/ prescription-medicines/lamictal.htm. Accessed 25 Oct 2011.
-
(2011)
GlaxoSmithKline
-
-
-
3
-
-
39749110172
-
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (the COMPASS study)
-
17825077 10.1111/j.1528-1167.2007.01274.x 1:CAS:528:DC%2BD1cXktVOjs7Y%3D
-
Tompson DJ, Ali I, Oliver-Willwong R, et al. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (the COMPASS study). Epilepsia. 2008;49:410-7.
-
(2008)
Epilepsia
, vol.49
, pp. 410-417
-
-
Tompson, D.J.1
Ali, I.2
Oliver-Willwong, R.3
-
4
-
-
60549112029
-
Once-daily lamotrigine extended release for epilepsy management
-
19210192 10.1586/14737175.9.2.167 1:CAS:528:DC%2BD1MXhslyisrs%3D
-
Rheims S, Ryvlin P. Once-daily lamotrigine extended release for epilepsy management. Expert Rev Neurother. 2009;9:167-73.
-
(2009)
Expert Rev Neurother
, vol.9
, pp. 167-173
-
-
Rheims, S.1
Ryvlin, P.2
-
5
-
-
0034871011
-
A systematic review of the associations between dose regimens and medication compliance
-
11558866 10.1016/S0149-2918(01)80109-0 1:STN:280:DC%2BD3MrhtVKktA%3D%3D
-
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-310.
-
(2001)
Clin Ther
, vol.23
, pp. 1296-1310
-
-
Claxton, A.J.1
Cramer, J.2
Pierce, C.3
-
6
-
-
0028889303
-
Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial
-
7588455 10.1111/j.1528-1157.1995.tb00469.x 1:CAS:528:DyaK2MXpsl2ktr8%3D
-
Cramer J, Vachon L, Desforges C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia. 1995;36:1111-7.
-
(1995)
Epilepsia
, vol.36
, pp. 1111-1117
-
-
Cramer, J.1
Vachon, L.2
Desforges, C.3
-
7
-
-
0033868589
-
Antiepileptic drug treatment: Outcomes and adherence
-
10937819 10.1592/phco.20.12.191S.35250 1:CAS:528:DC%2BD3cXlvVyhur0%3D
-
Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy. 2000;20:191S-9S.
-
(2000)
Pharmacotherapy
, vol.20
-
-
Garnett, W.R.1
-
8
-
-
0030978056
-
Factors influencing compliance with antiepileptic drug regimes
-
9153719 10.1016/S1059-1311(97)80060-X 1:STN:280:DyaK2s3pvVaksw%3D%3D
-
Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes. Seizure. 1997;6:87-93.
-
(1997)
Seizure
, vol.6
, pp. 87-93
-
-
Buck, D.1
Jacoby, A.2
Baker, G.A.3
Chadwick, D.W.4
-
9
-
-
0036669376
-
The relationship between poor medication compliance and seizures
-
Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav. 2002;3:228-42.
-
(2002)
Epilepsy Behav
, vol.3
, pp. 228-242
-
-
Cramer, J.A.1
Glassman, M.2
Rienzi, V.3
-
10
-
-
33645580598
-
Variability of antiepileptic medication-taking behaviour in sudden unexplained death in epilepsy: Hair analysis at autopsy
-
16543526 10.1136/jnnp.2005.067777 1:STN:280:DC%2BD287lsVWmtw%3D%3D
-
Williams J, Lawthom C, Dunstan FD, et al. Variability of antiepileptic medication-taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy. J Neurol Neurosurg Psychiatry. 2006;77:481-4.
-
(2006)
J Neurol Neurosurg Psychiatry
, vol.77
, pp. 481-484
-
-
Williams, J.1
Lawthom, C.2
Dunstan, F.D.3
-
11
-
-
35848947010
-
Lamotrigine extended-release as adjunctive therapy for partial seizures
-
17938371 10.1212/01.wnl.0000277698.33743.8b 1:CAS:528:DC%2BD2sXhtFekt73M
-
Naritoku DK, Warnock CR, Messenheimer JA, et al. Lamotrigine extended-release as adjunctive therapy for partial seizures. Neurology. 2007;69:1610-8.
-
(2007)
Neurology
, vol.69
, pp. 1610-1618
-
-
Naritoku, D.K.1
Warnock, C.R.2
Messenheimer, J.A.3
-
12
-
-
78649904882
-
Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study
-
20937567 10.1016/j.yebeh.2010.07.022
-
Biton V, DiMemmo J, Shukla R, et al. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav. 2010;19:352-8.
-
(2010)
Epilepsy Behav
, vol.19
, pp. 352-358
-
-
Biton, V.1
Dimemmo, J.2
Shukla, R.3
-
13
-
-
84856611764
-
Lamotrigine XR conversion to monotherapy: First study using a historical control group
-
22139591 10.1007/s13311-011-0088-3 1:CAS:528:DC%2BC38XhvFantrg%3D
-
French JA, Temkin N, Shneker BF, et al. Lamotrigine XR conversion to monotherapy: first study using a historical control group. Neurotherapeutics. 2012;9:176-84.
-
(2012)
Neurotherapeutics
, vol.9
, pp. 176-184
-
-
French, J.A.1
Temkin, N.2
Shneker, B.F.3
-
15
-
-
0031955433
-
Safety review of adult clinical trial experience with lamotrigine
-
9565739 10.2165/00002018-199818040-00004 1:CAS:528:DyaK1cXislCjs7Y%3D
-
Messenheimer J, Mullens EL, Giorgi L, et al. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. 1998;18:281-96.
-
(1998)
Drug Saf
, vol.18
, pp. 281-296
-
-
Messenheimer, J.1
Mullens, E.L.2
Giorgi, L.3
-
16
-
-
0021043873
-
Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy
-
Keranen T, Sivenius J. Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. Acta Neurol Scand Suppl. 1982;97:69-80.
-
(1982)
Acta Neurol Scand Suppl
, vol.97
, pp. 69-80
-
-
Keranen, T.1
Sivenius, J.2
-
17
-
-
0026013102
-
A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine
-
2036618 1:STN:280:DyaK3M3ktlSrsQ%3D%3D
-
Dhalla Z, Bruni J, Sutton J. A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine. Can J Neurol Sci. 1991;18:66-8.
-
(1991)
Can J Neurol Sci
, vol.18
, pp. 66-68
-
-
Dhalla, Z.1
Bruni, J.2
Sutton, J.3
-
18
-
-
56749112207
-
Pharmacotherapeutics of epilepsy: Use of lamotrigine and expectations for lamotrigine extended release
-
19209284 1:CAS:528:DC%2BD1cXhsFers7zK
-
Werz MA. Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release. Ther Clin Risk Manag. 2008;4:1035-46.
-
(2008)
Ther Clin Risk Manag
, vol.4
, pp. 1035-1046
-
-
Werz, M.A.1
-
19
-
-
77958508858
-
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
-
Blaszczyck B, Czuczwar SJ. Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients. Neuropsychiatr Dis Treat. 2010;6:145-50.
-
(2010)
Neuropsychiatr Dis Treat
, vol.6
, pp. 145-150
-
-
Blaszczyck, B.1
Czuczwar, S.J.2
-
20
-
-
79952457600
-
Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: Focus on once-daily lamotrigine
-
21151621 1:CAS:528:DC%2BC3cXhsVOqtbrP
-
Steinbaugh L, Szaflarski JP. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine. Drug Des Devel Ther. 2010;4:337-42.
-
(2010)
Drug des Devel Ther
, vol.4
, pp. 337-342
-
-
Steinbaugh, L.1
Szaflarski, J.P.2
|